Kewaunee Scientific's strong FY2025 results, record backlog, and margin expansion signal a return to growth and improved business predictability. Adjusted EPS actually rose 28% year-over-year, once non-recurring items and acquisition costs are excluded, reflecting core operational strength. A 38% increase in backlog suggests robust revenue growth for FY2026, supporting a bullish outlook and mor...
STATESVILLE, N.C. , June 25, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its fourth quarter and its fiscal year ended April 30, 2025.
STATESVILLE, N.C. , June 11, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release financial results for its fourth quarter and fiscal year ended April 30, 2025 on Wednesday, June 25, 2025 after the close of trading.
STATESVILLE, N.C. , March 12, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced an amendment to its existing share repurchase program.
STATESVILLE, N.C. , March 12, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its third quarter ended January 31, 2025.
STATESVILLE, N.C. , Feb. 26, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release its third quarter fiscal year 2025 financial results on Wednesday, March 12, 2025 after the close of trading.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.